Financial Advocates Investment Management’s AbbVie ABBV Stock Holding History

Financial Advocates Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.09M	Buy	16,633 +5,928	+55%	+$1.1M	0.25%	88
2025 Q1	$2.24M	Sell	10,705 -16,263	-60%	-$3.41M	0.16%	152
2024 Q4	$4.79M	Sell	26,968 -1,939	-7%	-$345K	0.27%	79
2024 Q3	$5.71M	Buy	28,907 +194	+0.7%	+$38.3K	0.32%	71
2024 Q2	$4.92M	Sell	28,713 -4,632	-14%	-$794K	0.31%	74
2024 Q1	$6.07M	Buy	33,345 +501	+2%	+$91.2K	0.35%	71
2023 Q4	$5.09M	Sell	32,844 -507	-2%	-$78.6K	0.33%	71
2023 Q3	$4.97M	Sell	33,351 -213	-0.6%	-$31.8K	0.36%	71
2023 Q2	$4.52M	Buy	33,564 +67	+0.2%	+$9.03K	0.32%	76
2023 Q1	$5.34M	Sell	33,497 -1,318	-4%	-$210K	0.38%	55
2022 Q4	$5.63M	Buy	34,815 +10,473	+43%	+$1.69M	0.42%	53
2022 Q3	$3.27M	Sell	24,342 -8,694	-26%	-$1.17M	0.27%	96
2022 Q2	$5.06M	Buy	33,036 +3,166	+11%	+$485K	0.41%	59
2022 Q1	$4.84M	Buy	29,870 +993	+3%	+$161K	0.32%	76
2021 Q4	$3.91M	Buy	28,877 +4,684	+19%	+$634K	0.25%	96
2021 Q3	$2.61M	Buy	24,193 +2,146	+10%	+$231K	0.18%	139
2021 Q2	$2.44M	Sell	22,047 -2,865	-12%	-$318K	0.16%	145
2021 Q1	$2.7M	Buy	24,912 +178	+0.7%	+$19.3K	0.19%	120
2020 Q4	$2.65M	Buy	24,734 +1,047	+4%	+$112K	0.18%	122
2020 Q3	$2.08M	Buy	23,687 +3,553	+18%	+$311K	0.18%	117
2020 Q2	$1.98M	Buy	20,134 +2,413	+14%	+$237K	0.19%	121
2020 Q1	$1.35M	Buy	17,721 +3,010	+20%	+$229K	0.19%	144
2019 Q4	$1.3M	Buy	14,711 +1,306	+10%	+$116K	0.14%	171
2019 Q3	$1.02M	Buy	13,405 +2,150	+19%	+$163K	0.12%	185
2019 Q2	$818K	Buy	11,255 +1,608	+17%	+$117K	0.09%	209
2019 Q1	$777K	Buy	9,647 +104	+1%	+$8.38K	0.1%	206
2018 Q4	$880K	Buy	9,543 +80	+0.8%	+$7.38K	0.12%	184
2018 Q3	$895K	Buy	9,463 +268	+3%	+$25.3K	0.1%	204
2018 Q2	$856K	Buy	9,195 +296	+3%	+$27.6K	0.1%	204
2018 Q1	$842K	Buy	8,899 +2,967	+50%	+$281K	0.11%	194
2017 Q4	$574K	Buy	+5,932	New	+$574K	0.08%	237